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Abstract
Spindle cell carcinoma (SpCC) is a variant of squamous cell carcinoma with biphasic components and more aggressive 
behaviour. Its rarity and histopathological pattern pose a diagnostic challenge. Early diagnosis and treatment result in a 
decrease in local and distant metastasis. Case 1 is a 71-year-old female presented with hoarseness of voice and dyspnoea for 
2 years without any risk factors. Fibre-optic laryngoscopy (FOL) revealed smooth polyp hanging from anterior two-third of 
the left vocal cord. Microlaryngoscopic excision revealed SpCC followed by post-operative radiotherapy and is currently 
alive. Case 2 is a 72-year-old male presented with worsening stridor for 2 years post-excision of laryngeal nodule and history 
of smoking and hookah use for >20 years. He developed dysphonia after a few months with fixed hard level 3 nodes at 
the right side. FOL showed a polypoid mass extending from the left vocal cord into the supraglottis. Fine-needle aspiration 
cytology of the neck swelling confirmed the diagnosis of SpCC. Computerised tomography (CT) chest/abdomen showed 
distant metastasis. Palliative radiotherapy was given, but the patient died after 3 months due to locoregional failure. Case 3 
is a 35-year-old male presented with a history of hoarseness for 3 years with no risk factors. FOL showed a 1.2-cm polypoid 
growth on the right vocal cord. Total laryngectomy was performed and histopathology showed SpCC. Radiotherapy was 
given and the patient is alive without disease with regular follow-ups. Smoking and alcohol are thought to be the contributing 
factors causing this disease. Biphasic nature of the tumour requires pathological sampling for diagnostic confirmation. 
Surgery combined with radiotherapy has a better survival outcome. SpCC is a rare tumour with a tendency for locoregional 
recurrence. Surgery should remain the mainstay of treatment followed by post-operative radiotherapy for a better control.
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Introduction
Spindle cell carcinoma (SpCC) is a more aggressive and 
malignant form of squamous cell carcinoma, comprising 
2–3% of all laryngeal cancers.[1-3] Histologically, it 
has a biomorphic pattern composed of both epithelial 
and mesenchymal components. Epithelial component 
comprises of squamous cell (in situ or invasive) and 
mesenchymal with spindle cells.[4]
The carcinoma has male preponderance and occurs more 
commonly in sixth or seventh decades of life with a 5-year 
survival of 65–95%.[5] The prognosis of SpCC is excellent 
depending on the stage of the tumour and regional nodal 
metastasis which is seen in one-quarter of the cases and 
distant metastasis occurs in 5–15%.[6] The most common 
site of distant metastasis is the lung, followed by soft 
tissues and other viscera. The rate of local recurrence is 
7–26%. In most instances, the relapses occurred within 
12 months of initial treatment.[7]
The calamity of the disease is a difficult diagnosis and 
definitive management to avoid recurrence. In this case 
series, we have discussed the clinicopathological aspects 
of four cases of SpCC along with its management.
Case Report
Case 1
A 71-year-old Bengali woman presented at head and 
neck clinic. The presenting complaints were hoarseness 
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of voice and occasional difficulty in breathing for the 
past 2 years. She had no history of smoking or any other 
addiction. Her flexible fibre-optic laryngoscope (FOL) 
examination showed a large smooth surface polyp 
hanging from anterior two-third of the left vocal cord 
with both cords being symmetrically mobile. Later that 
month, microlaryngoscopic excision was performed and 
histopathology revealed SpCC [Figure 1]. The post-
operative magnetic resonance imaging (MRI) scan showed 
nodularity along the left vocal cord without significant 
neck nodal disease with the American Joint Committee 
on Cancer (AJCC) stage-I (T1N0M0). She received 
hypofractionated radiotherapy of 55 Grey in 20 fractions 
(275cGy/fraction). The patient did well and went back to 
her country and is alive till date.
Case 2
A 72-year-old male presented at the head and neck clinic 
with worsening hoarseness for the past2 years. He had 
been smoking cigarettes and hookah for the past 20 years. 
He started his treatment 6 months earlier with excision of 
laryngeal nodule performed at another centre. Histology 
of the surgical specimen was inconclusive at that time. He 
developed dysphonia again after a few months, for which 
he was brought to our institute. Clinically, he had a hard 
and fixed nodal swelling at level III on the right side of the 
neck. FOL showed a polypoid mass extending from the 
left vocal cord into the supraglottis. Fine-needle aspiration 
of the neck swelling was done which confirmed the 
diagnosis of SpCC. Computerised tomography (CT) neck 
showed nodular thickening of the left vocal cord extending 
up to the anterior commissure. There is a evidence of 
supraglottic extension with the involvement of ipsilateral 
aryepiglottic fold, resulting in obliteration of pyriform 
fossa, while CT-chest/abdomen and chest x-ray confirmed 
the presence of extensive pulmonary, pleural and hepatic 
metastatic disease [Figure 2]. Meanwhile, the patient 
developed dyspnoea and stridor, for which emergency 
tracheostomy was done. Palliative radiotherapy of 20 Gy 
in 5 fractions was given and he died after 3 months due 
to progressive local and distant disease.
Case 3
A 35-year-old male presented at radiation oncology 
department with complaints of hoarseness for the past 
3 years. There was no history of any addiction reported. 
FOL showed a 1.2-cm polypoid growth on the right vocal 
cord. Lymph nodes were not palpable. Excision biopsy done 
at another centre showed high-grade sarcoma. CT neck 
also showed T3 disease due to paraglottic extension with 
bilateral tiny sub centimetre radiologically insignificant 
lymph nodes. Thus, a total laryngectomy was performed 
and biopsy revealed SpCC. On gross examination, the 
larynx contained a polypoid well-circumscribed tumour 
measuring 1.2 cm × 1.0 cm × 0.6 cm, present on the right 
side involving the glottic area and extending into the 
subglottis. Histological examination revealed a tumour 
showing foci of squamous cell carcinoma in situ with 
focal invasive component [Figure 3]. Bulk of the tumour 
was formed by spindle cells with elongated nuclei and 
Figure 1: Low power magnification (×10) showing tumour 
comprising interlacing bundles and fascicles (indicated by arrow)
Figure 2: Chest X-ray showing lung metastasis
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these cells were negative for CK5/6. However, CK5/6 was 
positive in epithelial component.
These findings favoured carcinosarcoma (SpCC). The 
tumour invades into the paraglottic space. All resection 
margins were free of tumour. A radiation dose of 50 Gy 
in 20 fractions was given to neck including primary 
and bilateral cervical nodes. The patient has maintained 
regular follow-up visits and is free of disease till date.
Discussion
SpCC is a rare and highly malignant variant of squamous 
cell carcinoma. It has been referred to by a number of 
terms such as pseudo-carcinoma, pleomorphic carcinoma, 
collision tumours, combination tumours, composition 
tumour, Lane’s tumour and polypoid carcinoma.[8] This 
is explained by the fact that the true nature of the disease 
has remained controversial for a long time. The incidence 
is 2–3% of all laryngeal cancers. The real cause, like most 
of the other carcinomas, is not known. However, the risk 
factors include cigarette smoking and alcohol consumption. 
Many cases reported a history of radiation exposure, but 
there is no definitive evidence to prove this hypothesis.[9-11]
The SpCC more commonly involves glottis than any 
other subsites in the larynx. Therefore, clinically, patients 
present with complaints of hoarseness, dysphonia, 
dysphagia and foreign body sensations in the throat. 
Mostly, tumours are pedunculated, exophytic or polypoid 
in clinical examination causing obstructive respiratory 
symptoms at an early stage leading to prompt diagnosis 
and treatment of the tumour. One-quarter of patients 
presents with nodal metastasis, and distant metastasis is 
seen in 5–15%. One of our patients presented not only 
with nodal metastasis but also with extensive lung and 
liver metastasis which signify the appropriate staging 
workup before the start of radical treatment.
Pathological examination of the biopsy specimen leads 
to definitive diagnosis. The tumour has a biphasic pattern 
composed of both carcinomatous and sarcomatoid 
component. Typically, a confirmation is achieved by the 
observation of surface epithelial cells with underlying 
sarcomatoid spindle-shaped neoplastic proliferation. In case 
of surface ulceration or denuded epithelium, the dignity 
remains undefined and diagnosis of SpCC is difficult to 
render. The pathogenesis of SpCC is controversial and its 
derivation has remained ambiguous till date. Although there 
are no large mass studies available that suggest the epithelial 
origin of the tumour, a few histological theories are certain 
in favour of it including (1) its location and occurrence 
which are at the site of squamous epithelium, (2) neoplastic 
mesenchymal spindle cells occurring in association with 
nests of benign or malignant squamous epithelium, (3) 
there polyploid nature and (4) immunohistochemical 
analysis shows reactivity to epithelial antigen. However, 
there are many evidence that demonstrate metastasis of 
both sarcomatoid and epithelial components in a single 
lymph node or separate metastasis of individual component 
to various sites, suggesting that sarcomatoid spindle cells 
are not just a metaplastic reaction to overlying malignant 
epithelium rather it’s an independent morphology fully 
capable of having its own natural course.
In addition to histological studies, immunohistochemistry 
also demonstrates two distinct pathologies. The epithelial 
component is positive for a panel of keratin markers 
(AE1/AE3 ‘CK1’), epithelial membrane antigen, K1 and 
K18, and the mesenchymal component is positive for 
variable smooth muscle actin, S-100 protein, muscle-
specific actin, desmin-D33 and desmin-DR11. However, 
both components are positive for vimentin; however, it is 
more expressed in sarcomatoid component of the tumour or 
in those epithelial cells that show metaplastic mesenchymal 
transformation while losing their ability to react with 
Figure 3: Squamous cell carcinoma with sarcomatoid features 
comprising spindle-shaped tumour cells (indicated by thick 
arrow) and markedly pleomorphic cells (thin arrow). H and E, 
×20 magnification
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epithelial markers. p53 is an epithelial cell proliferation 
and differentiation marker and is important in confirming 
the diagnosis of SpCC of the head and neck region.
SpCC is staged according to AJCC TNM staging 
system based on tumour size and presence or absence of 
locoregional lymph node and distant metastasis.
There is no consensus available yet on treatment modality 
of SpCC. The goals of the treatment include cancer cure, 
organ preservation, good voice quality and low risks of 
complications. Surgery and radiation are the two treatment 
options available, but surgery remains the mainstay of the 
treatment. The choice depends on the stage and location of 
tumour. For small stage tumours T1 and T2 polypectomy, 
microlaryngoscopic excision or vocal cord stripping followed 
by adjuvant radiotherapy is considered as the treatment of 
choice. However, Thompson et al., in their study, showed 
that patients who were managed by surgery alone had a better 
outcome than the patients who were treated with surgery and 
adjuvant radiotherapy. The group of patients who were treated 
with radiation alone and those who were treated with radiation 
and surgery both had a better survival (3.6 years) compared 
to those who were treated with surgery alone (1.9 years). 
Theoretically, some studies also show that the use of radiation 
therapy in SpCC is not suggested because mesenchymal 
component of the disease is highly resistant to radiation. For 
advance, high stage (T3 and T4) and recurrent tumours, a more 
aggressive approach is adapted including hemilaryngectomy 
or total laryngectomy with or without lymph node dissection 
followed by post-operative radiotherapy.[12-15] In one of our 
case reports, advance SpCC with extensive liver and lung 
metastasis is discussed in which salvage surgery and palliative 
radiotherapy were adopted which showed the survival of 
2 years. Radiation alone might not be the control of the 
disease, but, when combined with salvage surgery, it has a 
survival of 79–98% in recurrent diseases.
Conclusion
SpCC is a rare but aggressive variant of squamous cell 
carcinoma. As there are chances of local as well as distant 
metastatic disease, so cross-sectional imaging of lungs and 
liver should be incorporated in routine staging workup. Origin 
of the tumour remains controversial so is its definitive mode of 
treatment. With our case series, we conclude that surgery must 
be the mainstay of treatment, but adjuvant radiation should 
be combined to have good locoregional controls.
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